Clotrimazole Topical Solution USP,1%

Manufacturer
Akron Pharma Inc
Effective date
2026-05-05
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-06-01 01:56:04

Label at a glance#

ProductClotrimazole
Active ingredientCLOTRIMAZOLE
Label structure10 sections

Indications and uses

Cures most Athlete's foot (tinea pedis) Jock Itch (tinea cruris) Ringworm (tinea corporis) Effectively relieves Itching Cracking Burning Discomfort which can accompany these conditions

Dosage and administration

This product is not effective on the scalp or nails For best results, follow directions and continue treatment for length of time indicated. For athlete's foot and ringworm: use daily for 4 weeks. For jock itch: use daily for 2 weeks. clean the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the u...

Storage and handling

Store at 15° to 30°C (59° to 86°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole USP, 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

Cures most

  • Athlete's foot (tinea pedis)
  • Jock Itch (tinea cruris)
  • Ringworm (tinea corporis)

Effectively relieves

  • Itching
  • Cracking
  • Burning

Discomfort which can accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Ask a doctor before use

OTC - ASK DOCTOR SECTION

on children under 2 years of age

When using this product

OTC - WHEN USING SECTION

avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation occurs
  • there is no improvement within 4 weeks (for athlete's foot and ringworm) or 2 weeks (for jock itch)

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • This product is not effective on the scalp or nails For best results, follow directions and continue treatment for length of time indicated. For athlete's foot and ringworm: use daily for 4 weeks. For jock itch: use daily for 2 weeks.
  • clean the affected area and dry thoroughly
  • apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product

For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes; change shoes and socks at least once daily

Other information

STORAGE AND HANDLING SECTION

  • Store at 15° to 30°C (59° to 86°F)

Inactive ingredient

INACTIVE INGREDIENT SECTION

polyethylene glycol 400

Questions?

OTC - QUESTIONS SECTION

Please Call 1-877-225-6999

PRINCIPAL DISPLAY PANEL - 10 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 71399-0500-1

Compare to the active ingredient of Lotrimin ®AF*

Clotrimazole Topical Solution USP,1%

Antifungal

  • Relieves Itching & Burning
  • Greaseless, Nonstaining

For External use only.
Not for Opthalmic use.

Keep this and all medications out of the reach of children .

Akron Pharma

10ml

LabelLabel​​​

NDC 71399-0500-3

Compare to the active ingredient of Lotrimin®AF*

Clotrimazole Topical Solution USP,1%

Antifungal

Relieves Itching & Burning
Greaseless, Nonstaining
For External use only.
Not for Opthalmic use.

Keep this and all medications out of the reach of children.

Akron Pharma

30ml

30ml30ml

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71399-0500-1Clotrimazole10 mL in 1 BOTTLESOLUTION107
71399-0500-3Clotrimazole30 mL in 1 BOTTLESOLUTION307

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71399-0500-1ML - Milliliter71399-0500f52e02f7-cb2c-408f-8468-a14d5f7184f912017-07-07
71399-0500-3ML - Milliliter71399-05007f97a0cd-9b52-49ad-a1e2-cab2d8d8bb7212023-03-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71399-050071399-0500-1, 71399-0500-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYETHYLENE GLYCOL 400B697894SGQIACT
CLOTRIMAZOLEG07GZ97H65ACTIB

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
62026-01-19monthly-update2026-06-03 17:53:00

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ClotrimazoleCLOTRIMAZOLEAkron Pharma Inc692d7e0f-50d4-4abb-8c74-36bc98064fe72026-05-05WarningsExact identifier
ndc (package): 71399-0500-1
ndc (package): 71399-0500-3
ndc (product): 71399-0500
ndc11 (package): 71399050003
ndc11 (package): 71399050001
spl id: 5113af13-6054-1881-e063-6394a90aa5fc
spl set id: 692d7e0f-50d4-4abb-8c74-36bc98064fe7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.